Medroxyprogesterone
Also known as Curretab
Medroxyprogesterone (INN, BAN), also known as 17α-hydroxy-6α-methylprogesterone, and abbreviated as MP, is a steroidal progestin drug which was never marketed for use in humans. An acylated derivative, medroxyprogesterone acetate (MPA), is clinically used as a pharmaceutical medicine. Compared to MPA, MP is over two orders of magnitude less potent as a progestogen. As such, MP itself is not used clinically, though it has seen limited use in veterinary medicine under the trade name Controlestril in France. In addition, it is an metabolite of MPA.
Source: WikipediaEstimated Total Cost: $11.2 for an average of 28 days supply
What is it prescribed for?
Patients are most commonly prescribed medroxyprogesterone to treat idiopathic irregular menstrual cycle, idiopathic excessive menstruation, idiopathic absence of menstruation, and uterine fibroids.
What drug interactions are known?
Critical Interactions
Significant Interactions
What side effects are related?
Patients taking medroxyprogesterone most commonly experience side effects like headache, pain or soreness of breast, and pain.
Loading...